Mirae Asset Global Investments Co., Ltd.

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1569395 SEOUL, M5

Position in RYTM

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$340,640

+$30,853 QoQ

Shares Held

3,068

-13.9% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#208

of 299 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Mirae Asset Global Investments Co., Ltd. holds $279,047,947 across 206 Biotechnology names. RYTM ranks #38 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	210,209	$104,417,115
2	REGN	Regeneron Pharmaceuticals, Inc.	93,632	$58,383,296
3	ALNY	Alnylam Pharmaceuticals, Inc.	61,531	$18,522,675
4	MDGL	Madrigal Pharmaceuticals, Inc.	33,420	$17,944,868
5	ARGX	Argenx SE	11,164	$10,357,623
6	ONC	BeOne Medicines Ltd.	33,808	$9,634,265
7	RPRX	Royalty Pharma plc	150,556	$8,441,674
8	INCY	Incyte Corp	63,812	$7,233,728

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$340,640	3,068	-13.9%	Shares	Sole	2026-07-22
2026-03-31	$309,787	3,562	+9.8%	Shares	Sole	2026-05-04
2025-12-31	$347,130	3,243	+26.3%	Shares	Sole	2026-01-26
2025-09-30	$259,342	2,568	+4.5%	Shares	Sole	2025-11-03
2025-06-30	$155,321	2,458	+16.2%	Shares	Sole	2025-07-21
2025-03-31	$112,084	2,116	+3.3%	Shares	Sole	2025-04-24
2024-12-31	$114,647	2,048	-7.4%	Shares	Sole	2025-01-27
2024-09-30	$115,834	2,211	+21.5%	Shares	Sole	2024-10-23
2024-06-30	$74,729	1,820	-93.8%	Shares	Sole	2024-07-30
2023-12-31	$1,353,539	29,444	-2.9%	Shares	Defined	2024-01-24
2023-09-30	$695,382	30,333	-10.7%	Shares	Sole	2023-10-26
2023-06-30	$560,395	33,984	+207.4%	Shares	Defined	2023-08-10
2023-03-31	$197,238	11,056	—	Shares	Defined	2023-05-04
No filing history on record for this holder in this stock.